Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 263 of the 264 references it cites were found in a registry or an index.

Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology

Open access
Peet, Bradley T., Spina, Salvatore, Mundada, Nidhi, La Joie, Renaud · 2021 · Neurotherapeutics

Abstract

Frontotemporal dementia encompasses a group of clinical syndromes defined pathologically by degeneration of the frontal and temporal lobes. Historically, these syndromes have been challenging to diagnose, with an average of about three years between the time of symptom onset and the initial evaluation and diagnosis. Research in the field of neuroimaging has revealed numerous biomarkers of the various frontotemporal dementia syndromes, which has provided clinicians with a method of narrowing the differential diagnosis and improving diagnostic accuracy. As such, neuroimaging is considered a core investigative tool in the evaluation of neurodegenerative disorders. Furthermore, patterns of neurodegeneration correlate with the underlying neuropathological substrates of the frontotemporal dementia syndromes, which can aid clinicians in determining the underlying etiology and improve prognostication. This review explores the advancements in neuroimaging and discusses the phenotypic and pathologic features of behavioral variant frontotemporal dementia, semantic variant primary progressive aphasia, and nonfluent variant primary progressive aphasia, as seen on structural magnetic resonance imaging and positron emission tomography.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13311-021-01101-x

Cites

263 of 263 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Patterns of atrophy and hypometabolism associated with FTD clinical syndromes. Group-level maps depicting gray matter atrophy compared to controls are shown on three-dimensional renders of the brain. Hypometabolism on FDG-PET is shown for individual patients, represented as Z score maps depicting abnormalities compared to controls. Adapted with permission from Whitwell 2019 [258]
Fig. 1 Patterns of atrophy and hypometabolism associated with FTD clinical syndromes. Group-level maps depicting gray matter atrophy compared to controls are shown on three-dimensional renders of the brain. Hypometabolism on FDG-PET is shown for individual patients, represented as Z score maps depicting abnormalities compared to controls. Adapted with permission from Whitwell 2019 [258]CC BY · PubMed Central
Fig. 2 Neuroimaging of bvFTD associated with FTLD-TDP type A and B (top row: structural MRI; bottom row: FDG-PET). The variability in patterns of degeneration attributed to FTLD-TDP neuropathology is readily seen in these two cases of bvFTD. In the case of bvFTD associated with FTLD-TDP type A, degeneration and hypometabolism of the bilateral frontal lobes are present; however, the left is significantly more impacted than the right and extends to the left parietal lobe. In bvFTD associated with FTLD-TDP type B, significant degeneration of the bilateral frontal lobes is seen; however, in contrast to type A, the parietal lobes are less affected and atrophy is relatively symmetrical
Fig. 2 Neuroimaging of bvFTD associated with FTLD-TDP type A and B (top row: structural MRI; bottom row: FDG-PET). The variability in patterns of degeneration attributed to FTLD-TDP neuropathology is readily seen in these two cases of bvFTD. In the case of bvFTD associated with FTLD-TDP type A, degeneration and hypometabolism of the bilateral frontal lobes are present; however, the left is significantly more impacted than the right and extends to the left parietal lobe. In bvFTD associated with FTLD-TDP type B, significant degeneration of the bilateral frontal lobes is seen; however, in contrast to type A, the parietal lobes are less affected and atrophy is relatively symmetricalCC BY · PubMed Central
Fig. 3 Neuroimaging patterns associated with FTLD-TDP type C. FTLD-TDP type C typically exhibits significant anterior temporal lobe degeneration, which strongly lateralizes to either the left or right hemisphere. In cases of left lateralization, the clinical syndrome is typically consistent with svPPA, whereas in cases of right lateralization, there is a greater degree of behavioral symptoms, and language deficits are not typically the initial symptoms
Fig. 3 Neuroimaging patterns associated with FTLD-TDP type C. FTLD-TDP type C typically exhibits significant anterior temporal lobe degeneration, which strongly lateralizes to either the left or right hemisphere. In cases of left lateralization, the clinical syndrome is typically consistent with svPPA, whereas in cases of right lateralization, there is a greater degree of behavioral symptoms, and language deficits are not typically the initial symptomsCC BY · PubMed Central
Fig. 4 Gray matter atrophy associated with FTLD-TDP type C: left and right variants. All patients had pathology-proven TDP-C but were classified as having either a left- (n = 18) or right- (n = 12) predominant pattern of atrophy on ante mortem MRIs. At baseline, both groups show asymmetric but bilateral volume reduction in the temporal lobes, with a strong predominance in anterior and medial areas. In patients with multiple MRIs (n = 13 left- and 4 right-predominant cases), longitudinal analyses revealed that in both subgroups, atrophy progressed to the contralateral hemisphere and to more posterior temporal areas. Adapted with permission from Borghesani 2020 [179]
Fig. 4 Gray matter atrophy associated with FTLD-TDP type C: left and right variants. All patients had pathology-proven TDP-C but were classified as having either a left- (n = 18) or right- (n = 12) predominant pattern of atrophy on ante mortem MRIs. At baseline, both groups show asymmetric but bilateral volume reduction in the temporal lobes, with a strong predominance in anterior and medial areas. In patients with multiple MRIs (n = 13 left- and 4 right-predominant cases), longitudinal analyses revealed that in both subgroups, atrophy progressed to the contralateral hemisphere and to more posterior temporal areas. Adapted with permission from Borghesani 2020 [179]CC BY · PubMed Central
Fig. 5 Neuroimaging patterns associated with Pick’s disease (FTLD-tau, 3R). Structural MRI and FDG-PET demonstrating the variability in patterns of atrophy and hypometabolism attributed to Pick’s disease (3R tau) neuropathology. In the case of bvFTD, significant bilateral frontal lobe atrophy and hypometabolism is seen. In the case of nfvPPA, atrophy and hypometabolism is lateralized and is greatly impacting the left frontal lobe more so than the right.
Fig. 5 Neuroimaging patterns associated with Pick’s disease (FTLD-tau, 3R). Structural MRI and FDG-PET demonstrating the variability in patterns of atrophy and hypometabolism attributed to Pick’s disease (3R tau) neuropathology. In the case of bvFTD, significant bilateral frontal lobe atrophy and hypometabolism is seen. In the case of nfvPPA, atrophy and hypometabolism is lateralized and is greatly impacting the left frontal lobe more so than the right.CC BY · PubMed Central
Fig. 6 Neuroimaging patterns associated with 4R tauopathies (FTLD-tau). Structural MRI and FDG-PET demonstrating the variability in patterns of atrophy and hypometabolism attributed to 4R tauopathies, CBD and PSP
Fig. 6 Neuroimaging patterns associated with 4R tauopathies (FTLD-tau). Structural MRI and FDG-PET demonstrating the variability in patterns of atrophy and hypometabolism attributed to 4R tauopathies, CBD and PSPCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 264 references

Cited by

See all 85

Metadata

Authors
Peet, B. T., Spina, S., Mundada, N., & La Joie, R.
Affiliations
University of California, San Francisco (US)
Corresponding author
Peet, Bradley T.
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2021-04
Volume
18
Issue
2
Pages
728-752
ISSN
1878-7479 (ISSN-L)
OpenAlex
W3192508346
Cited by
74
References
264
Citations by year
2026: 14 · 2025: 17 · 2024: 19 · 2023: 13 · 2022: 8 · 2021: 2
FWCI
1.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurotherapeutics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (K08-AG052648, K99-AG065501)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal dementia, neuroimaging biomarkers, behavioral variant frontotemporal dementia, semantic dementia, neuropathology, differential diagnosis, structural MRI, positron emission tomography, outcome prediction
MeSH terms
Brain, Humans, Magnetic Resonance Imaging, Genetic Variation, Biomarkers, tau Proteins, Positron-Emission Tomography, Frontotemporal Dementia, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology. https://app.cochat.ai/papers/10.1007/s13311-021-01101-x
The paper
Peet, B. T., Spina, S., Mundada, N., & La Joie, R. (2021). Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology. Neurotherapeutics. https://doi.org/10.1007/s13311-021-01101-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.